DNM1L and breast carcinoma: Milani et al.32 found that DRP-1 is required for the effective killing induced by A-1210477 in lung, cervical, and breast cancer cell lines, whereas other studies show DRP-1 contributes to resistance, which has been seen in melanoma54,74.